Search For "leibniz institute for primate research"
Sun Pharma gets DCGI approval for clinical trial with Nafamostat in Covid-
Updated : 5 years, 12 months ago IST
Mumbai (Maharashtra) [India], May 29 (ANI): Sun Pharmaceutical Industries said on Friday it has received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamostat Mesilate in Covid-19 patients.
Read More